Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
100%
Pancreatic Cells
100%
Epigenetic Memory
100%
Stem Cell Lines
25%
Type 2 Diabetes Mellitus (T2DM)
12%
Clinical Implementation
12%
Drug Screening
12%
Stem Cell-derived
12%
Cell Differentiation
12%
Treatment Options
12%
Epigenetics
12%
Epigenome
12%
Replenishment
12%
Severe Disease
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Human Pluripotent Stem Cells (hPSCs)
12%
Differentiation Protocol
12%
Differentiation Potential
12%
Insulin-producing Cells
12%
Islet
12%
Islet Transplantation
12%
Diabetes Drugs
12%
Diabetes Therapy
12%
Therapies Screening
12%
Differentiation Efficiency
12%
Epigenetic Signature
12%
Differentiation Capacity
12%
Mitochondrial Dysfunction
12%
Low Efficiency
12%
Cell Replacement
12%
Autoimmune
12%
Impaired Insulin Secretion
12%
Multiple Mechanisms
12%
Long-term Glycaemic Control
12%
Pluripotent Stem Cell Differentiation
12%
Addition Strategy
12%
Cycle Type
12%
Donor Shortage
12%
Differentiation Propensity
12%
Cell Dedifferentiation
12%
Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
100%
Human Induced Pluripotent Stem Cell
100%
Epigenetic Memory
100%
Epigenetics
40%
Stem Cell Line
40%
Cellular Differentiation
40%
Reprogramming
40%
Epigenome
20%
Cell Cycle
20%
Insulin Release
20%
Hope
20%
Glycemic Control
20%
Cell Dedifferentiation
20%
Mitochondrial Disorder
20%
Neuroscience
In Vitro
100%
Stem Cell
100%
Cell Line
28%
Cellular Differentiation
28%
Reprogramming
28%
Cell Cycle
14%
Epigenome
14%
Diabetes Mellitus
14%
Diabetes Mellitus Type 1
14%
Cell Dedifferentiation
14%
Immunology and Microbiology
Induced Pluripotent Stem Cell
100%
Cell Differentiation
28%
Pluripotent Stem Cell Line
28%
Cell Cycle
14%
Islet Transplantation
14%
Insulin Release
14%
Diabetes Mellitus Type 1
14%
Insulin
14%
Glycemic Control
14%
Cell Dedifferentiation
14%